Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Long-Term Deferred Tax (2010 - 2013)

Utah Medical Products' quarterly Long-Term Deferred Tax came in at -$7454.0 in Q4 2013, down 1752.77% year-on-year from $451.0 in Q4 2012, and down 1752.77% quarter-over-quarter from $451.0 in Q4 2012.

Utah Medical Products has reported Long-Term Deferred Tax for 4 years, with the latest figure at -$7454.0 in Q4 2013.

  • For the quarter ending Q4 2013, Long-Term Deferred Tax fell 1752.77% year-over-year to -$7454.0; the trailing twelve-month figure through Dec 2013 stood at -$7454.0 (down 1752.77% YoY), and the FY2013 full-year result was -$7454.0, down 1752.77% from the prior year.
  • Long-Term Deferred Tax for Q4 2013 stood at -$7454.0, down from $451.0 in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $793000.0 in Q2 2011, with the low at -$7454.0 in Q4 2013.
  • Average Long-Term Deferred Tax over 4 years is $439399.4, with a median of $634000.0 recorded in 2010.
  • Peak annual rise in Long-Term Deferred Tax reached 1752.77% in 2013, while the deepest fall reached 1752.77% in 2013.
  • Tracing UTMD's Long-Term Deferred Tax over 4 years: stood at $634000.0 in 2010, then rose by 22.56% to $777000.0 in 2011, then sank by 99.94% to $451.0 in 2012, then plunged by 1752.77% to -$7454.0 in 2013.
  • The last three Long-Term Deferred Tax figures came in at -$7454.0 (Q4 2013), $451.0 (Q4 2012), and $777000.0 (Q3 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Utah Medical Products 204.80 Mn 117.39 Mn 5.28 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2013 -7,454.00
Dec 31, 2012 451.00
Sep 30, 2011 777,000.00
Jun 30, 2011 793,000.00
Dec 31, 2010 634,000.00